Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro

American Journal of Obstetrics and Gynecology

Volumn 191, Issue 6, 2004, Pages 2125-2131

  Bose, Patrick ^a,b   Black, Simon ^a   Kadyrov, Mamed ^a   Bartz, Clemens ^a   Shlebak, Abdul ^c   Regan, Lesley ^d   Huppertz, Berthold ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c Departments of Haematology

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Anticoagulants; Apoptosis; Heparin; Matrigel; Trophoblast

Indexed keywords

HEPARIN; LUPUS ANTICOAGULANT; MATRIGEL;

ADULT; APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; MITOSIS; NICK END LABELING; PLACENTA DISORDER; PLACENTA FUNCTION; PLACENTA VILLUS; PRIORITY JOURNAL; SERUM; TROPHOBLAST;

ABORTION, SPONTANEOUS; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; APOPTOSIS; BLOTTING, WESTERN; DNA FRAGMENTATION; FEMALE; HEPARIN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MITOSIS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TISSUE CULTURE TECHNIQUES; TROPHOBLASTS;

EID: 10044247005     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.05.014     Document Type: Article

References (27)

1. G.R. Hughes The anticardiolipin syndrome Clin Exp Rheumatol 3 1985 285 286
2. C.M. Celli, and A.E. Gharavi Origin and pathogenesis of antiphospholipid antibodies Braz J Med Biol Res 31 1998 723 732
3. R.S. Rai, L. Regan, K. Clifford, W. Pickering, M. Dave, and I. Mackie Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach Hum Reprod 10 1995 2001 2005
4. R.S. Rai, K. Clifford, H. Cohen, and L. Regan High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies Hum Reprod 10 1995 3301 3304
5. S. Donohoe, I.J. Mackie, D. Isenberg, and S.J. Machin Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome Br J Haematol 113 2001 544 549
6. J. Matsuda, N. Saitoh, K. Gohchi, M. Gotoh, and M. Tsukamoto Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody Am J Hematol 47 1994 56 58
7. D.M. Keeling, A.J. Wilson, I.J. Mackie, D.A. Isenberg, and S.J. Machin Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I J Clin Pathol 46 1993 665 667
8. R. Rai, H. Cohen, M. Dave, and L. Regan Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ 314 1997 253 257
9. M. Empson, M. Lassere, J.C. Craig, and J.R. Scott Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials Obstet Gynecol 99 2002 135 144
10. B.J. Woodhams, G. Candotti, R. Shaw, and P.B. Kernoff Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion Thromb Res 55 1989 99 107
11. B. Huppertz, P. Kaufmann, and J.C.P. Kingdom Trophoblast turnover in health and disease Fetal Matern Med Rev 13 2003 17 32
12. S. Yacobi, A. Ornoy, Z. Blumenfeld, and R.K. Miller Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture Teratol 66 2002 300 308
13. M. Greaves, H. Cohen, S.J. Machin, and I. Mackie Guidelines on the investigation and management of the antiphospholipid syndrome Br J Haematol 109 2000 704 715
14. J. Gong, F. Tragonas, and Z. Darzynkiewicz A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry Anal Biochem 218 1994 314 319
15. S. Black, H. Yu, J. Lee, M. Sachchithananthan, and R.L. Medcalf Physiologic concentrations of magnesium and placental apoptosis: prevention by antioxidants Obstet Gynecol 98 2001 319 324
16. H. Katsuragawa, H. Kanzaki, T. Inoue, T. Hirano, T. Mori, and N.S. Rote Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion Biol Reprod 56 1997 50 58
17. N. Di Simone, D. Caliandro, R. Castellani, S. Ferrazzani, S. De Carolis, and A. Caruso Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome Hum Reprod 14 1999 489 495
18. Y. Zhou, S.J. Fisher, M. Janatpour, O. Genbacev, E. Dejana, and M. Wheelock Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? J Clin Invest 99 1997 2139 2151
19. I.T. Chilcott, R. Margara, H. Cohen, R. Rai, J. Skull, and W. Pickering Pregnancy outcome is not affected by antiphospholipid status in women referred for in vitro fertilization Fertil Steril 73 2000 526 530
20. M.A. Birdsall, G.M. Lockwood, W.L. Ledger, P.M. Johnson, and L.W. Chamley Antiphospholipid antibodies in women having in-vitro fertilization Hum Reprod 11 1996 1185 1189
21. I.A. Brosens, W.B. Robertson, and H. Dixon The role of the spiral arteries in the pathogenesis of preeclampsia Obstet Gynecol Annu 1 1972 177 179
22. R.G. Farquharson, S. Quenby, and M. Greaves Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment Obstet Gynecol 100 2002 408 413
23. R.E. Leach, R. Khalifa, N.D. Ramirez, S.K. Das, J. Wang, and S.K. Dey Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation J Clin Endocrinol Metab 84 1999 3355 3363
24. K.L. Martin, D.H. Barlow, and I.L. Sargent Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium Hum Reprod 13 1998 1645 1652
25. M.P. Michalski, A. Kuhn, V. Mehta, and G.E. Besner Heparin-binding EGF-like growth factor decreases apoptosis in intestinal epithelial cells in vitro J Pediatr Surg 36 2001 1130 1135
26. S. Tanaka, T. Kunath, A.K. Hadjantonakis, A. Nagy, and J. Rossant Promotion of trophoblast stem cell proliferation by FGF4 Science 282 1998 2072 2075
27. D. Aviezer, M. Safran, and A. Yayon Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2 Biochem Biophys Res Commun 263 1999 621 626